Specialty Pharmacy

Rebekah L. Hanson, PharmD, BCPS, BCACP, clinical pharmacist and assistant professor at the UIC College of Pharmacy, discusses medication management processes that can improve adherence to specialty therapies.

Conference season can be a whirlwind and sometimes attendees are unable to do everything they had hoped to. SPT has compiled a list of how to get the most out of the National Association of Specialty Pharmacy conference.

An estimated 107,000 veterans are currently undiagnosed or untreated for HCV.

Researchers mimic the genetic mechanisms that block the development of Ras-dependent cancers.

Sunscreen can decrease the risk of melanoma by more than 30%.

Marc O'Connor, COO and chief strategy officer at Curant Health, discusses actions that can enhance the relationship between manufacturers, payers, providers and patients in specialty pharmacy.

Top news of the day from across the health care landscape.

A genetic modification prevented neuropathy in obese mice with diabetes.

Popular attractions of Washington, DC that may interest specialty pharmacists.

Less than 10% of young gay, bisexual, and other men who have sex with men have used HIV pre-exposure prophylaxis.

Non-invasive liquid biopsies may be more a more effective alternative to tissue biopsies in patients with advanced lung cancer.

Top news of the day from across the health care landscape.

Onduo use technological advances to enhance management of diabetes.

Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses access to cholesterol-lowering PCSK9 inhibitors and whether the hype regarding the impact of these medications was overblown.

Canagliflozin with extended release formulation of metformin improves blood glucose control in type 2 diabetes.

Clinical practice guidelines created for the treatment and diagnosis of lymphangioleiomyomatosis (LAM).

How to evaluate quality in pharmacies that offer distinct services to complex disease states, such as HIV, hemophilia, and oncology.

Marc O'Connor, COO and chief strategy officer at Curant Health, discusses the out-of-pocket costs that can emerge for patients starting a specialty medication regimen.

Pevonedistat, currently being tested in clinical trials, shows promise in killing melanomas and other cancer types.

An individual’s life expectancy after initiating therapy differs among high and middle/low-income countries.

Top news of the day from across the health care landscape.

National Health Checkup finds that cancer beat out infectious diseases as the biggest concern.

Exondys 51 granted accelerated approval to treat Duchenne muscular dystrophy.

Focus on the early stages of chronic obstructive pulmonary disease could prevent long-term lung function loss.

Mark Tesell, PharmD, BCPS, clinical consultant pharmacist at UMass Medical School, discusses the treatment switch from statins to PCSK9 inhibitors in patients with high cholesterol.

Top news of the day from across the health care landscape.

New strategy helps slow kidney disease progression that can occur in diabetes.

New insights pave the way for future treatment developments of pancreatic ductal adenocarcinoma.

HIV Test-and-Treat initiates antiretroviral therapy promptly, but may be too expensive to employ nationwide.

Top news of the week in oncology, and cancer drug development.